RecruitingNCT00556530
Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
Studying 22q11.2 deletion syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Albert Einstein College of Medicine
- Principal Investigator
- Bernice E. Morrow, PhDAlbert Einstein College of Medicine
- Enrollment
- 1000 enrolled
- Eligibility
- All sexes
- Timeline
- 2016 – 2029
Study locations (1)
- Albert Einstein College of Medicine, New York, New York, United States
Collaborators
National Heart, Lung, and Blood Institute (NHLBI) · Children's Hospital of Philadelphia · University of Geneva, Switzerland · University of Toronto, Centre for Addiction and Mental Health (CAMH) · Bambino Gesù Children's Hospital IRCCS · University of California, Los Angeles · Cardiff University · Universidad del Desarrollo · Tel Aviv University · KU Leuven · Maastricht University · The Coriell Institute · National Institute on Aging (NIA)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00556530 on ClinicalTrials.govOther trials for 22q11.2 deletion syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05664412Using Transcranial Alternating Current Stimulation to Improve Executive Function in 22q11.2 Deletion SyndromeStephan Eliez
- RECRUITINGNCT05924347Early Scoliotic Changes in Children at Increased Risk for Scoliosis DevelopmentUMC Utrecht
- RECRUITINGNCT05329935Congenital Athymia Patient RegistrySumitomo Pharma Switzerland GmbH
- RECRUITINGNANCT04639388Understanding of Psychotic Disorders in Children With 22q11.2DSHôpital le Vinatier